139 related articles for article (PubMed ID: 14688314)
1. The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cells.
Wang W; Ostlie NS; Conti-Fine BM; Milani M
J Immunol; 2004 Jan; 172(1):97-103. PubMed ID: 14688314
[TBL] [Abstract][Full Text] [Related]
2. Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice.
Karachunski PI; Ostlie NS; Monfardini C; Conti-Fine BM
J Immunol; 2000 May; 164(10):5236-44. PubMed ID: 10799884
[TBL] [Abstract][Full Text] [Related]
3. Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis.
Ostlie NS; Karachunski PI; Wang W; Monfardini C; Kronenberg M; Conti-Fine BM
J Immunol; 2001 Apr; 166(8):4853-62. PubMed ID: 11290761
[TBL] [Abstract][Full Text] [Related]
4. Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi.
Tarleton RL; Grusby MJ; Zhang L
J Immunol; 2000 Aug; 165(3):1520-5. PubMed ID: 10903759
[TBL] [Abstract][Full Text] [Related]
5. Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice.
Ostlie N; Milani M; Wang W; Okita D; Conti-Fine BM
J Immunol; 2003 Jan; 170(1):604-12. PubMed ID: 12496449
[TBL] [Abstract][Full Text] [Related]
6. Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling.
Nishikomori R; Usui T; Wu CY; Morinobu A; O'Shea JJ; Strober W
J Immunol; 2002 Oct; 169(8):4388-98. PubMed ID: 12370372
[TBL] [Abstract][Full Text] [Related]
7. Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury.
Yokota N; Burne-Taney M; Racusen L; Rabb H
Am J Physiol Renal Physiol; 2003 Aug; 285(2):F319-25. PubMed ID: 12709397
[TBL] [Abstract][Full Text] [Related]
8. The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis.
Balasa B; Deng C; Lee J; Christadoss P; Sarvetnick N
J Immunol; 1998 Sep; 161(6):2856-62. PubMed ID: 9743346
[TBL] [Abstract][Full Text] [Related]
9. Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets.
Nikolic B; Lee S; Bronson RT; Grusby MJ; Sykes M
J Clin Invest; 2000 May; 105(9):1289-98. PubMed ID: 10792004
[TBL] [Abstract][Full Text] [Related]
10. A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type 1 cells.
Kaplan MH; Wurster AL; Grusby MJ
J Exp Med; 1998 Sep; 188(6):1191-6. PubMed ID: 9743537
[TBL] [Abstract][Full Text] [Related]
11. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.
Deng C; Goluszko E; Christadoss P
J Immunol; 2001 Mar; 166(5):3458-67. PubMed ID: 11207304
[TBL] [Abstract][Full Text] [Related]
12. Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile.
Jankovic D; Kullberg MC; Noben-Trauth N; Caspar P; Paul WE; Sher A
J Immunol; 2000 Mar; 164(6):3047-55. PubMed ID: 10706693
[TBL] [Abstract][Full Text] [Related]
13. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis.
Chitnis T; Najafian N; Benou C; Salama AD; Grusby MJ; Sayegh MH; Khoury SJ
J Clin Invest; 2001 Sep; 108(5):739-47. PubMed ID: 11544280
[TBL] [Abstract][Full Text] [Related]
14. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection.
Shen XD; Ke B; Zhai Y; Gao F; Anselmo D; Lassman CR; Busuttil RW; Kupiec-Weglinski JW
Hepatology; 2003 Feb; 37(2):296-303. PubMed ID: 12540779
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: differential expression of chemokines in Th1 and Th2 cells is dependent on Stat6 but not Stat4.
Zhang S; Lukacs NW; Lawless VA; Kunkel SL; Kaplan MH
J Immunol; 2000 Jul; 165(1):10-4. PubMed ID: 10861028
[TBL] [Abstract][Full Text] [Related]
16. B7-1 costimulatory molecule is critical for the development of experimental autoimmune myasthenia gravis.
Poussin MA; Tüzün E; Goluszko E; Scott BG; Yang H; Franco JU; Christadoss P
J Immunol; 2003 Apr; 170(8):4389-96. PubMed ID: 12682276
[TBL] [Abstract][Full Text] [Related]
17. IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms.
Finnegan A; Grusby MJ; Kaplan CD; O'Neill SK; Eibel H; Koreny T; Czipri M; Mikecz K; Zhang J
J Immunol; 2002 Sep; 169(6):3345-52. PubMed ID: 12218156
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous administration of T-epitope sequences of the acetylcholine receptor prevents experimental myasthenia gravis.
Karachunski PI; Ostlie NS; Okita DK; Garman R; Conti-Fine BM
J Neuroimmunol; 1999 Jan; 93(1-2):108-21. PubMed ID: 10378874
[TBL] [Abstract][Full Text] [Related]
19. The homeostasis but not the differentiation of T cells is regulated by p27(Kip1).
Shen R; Kaplan MH
J Immunol; 2002 Jul; 169(2):714-21. PubMed ID: 12097373
[TBL] [Abstract][Full Text] [Related]
20. Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4.
Im SH; Barchan D; Maiti PK; Fuchs S; Souroujon MC
J Immunol; 2001 Jun; 166(11):6893-8. PubMed ID: 11359850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
